Literature DB >> 7536160

Inhibition of hind-paw edema and cutaneous vascular plasma extravasation in mice by acetylshikonin.

J P Wang1, S L Raung, L C Chang, S C Kuo.   

Abstract

Acetylshikonin, a naphthoquinone isolated from the Chinese herb medicine, tzu ts'ao, was demonstrated to inhibit the polymyxin B-induced hind-paw edema in normal as well as in adrenalectomized mice. Liver glycogen content was increased in adrenalectomized mice pretreated with dexamethasone, but not with acetylshikonin. Like diphenhydramine, methysergide and isoproterenol, acetylshikonin reduced the plasma exudation evoked in dorsal hind-paw skin by antidromic stimulation of the saphenous nerve, and in passive cutaneous anaphylactic reaction, bradykinin-, substance P-, compound 48/80-, histamine- and serotonin-induced ear edema. Indomethacin was ineffective in these respects. Bradykinin- and substance P-induced plasma exudation were also significantly reduced when [Thi5,8,D-Phe7]bradykinin and [D-Pro2,D-Trp7,9]substance P were coinjected with bradykinin and substance P, respectively. In isolated rat peritoneal mast cell preparation, acetylshikonin produced a concentration-dependent inhibition of histamine and beta-glucuronidase release from mast cells challenged by compound 48/80. In compound 48/80-pretreated mice, acetylshikonin and isoproterenol produced significantly more inhibitory effect on bradykinin- and substance P-induced plasma exudation than did diphenhydramine in combination with methysergide. Pretreatment with diphenhydramine/methysergide in compound 48/80-pretreated mice significantly further reduced the bradykinin- and substance P-induced plasma exudation if [Thi5,8,D-Phe7]bradykinin and [D-Pro2,D-Trp7,9]substance P were coinjected with bradykinin or substance P, respectively. The results suggest that the inhibitory effect of acetylshikonin on the edematous response is due neither to the release of steroid hormones from the adrenal gland nor to the glucocorticoid activity, but probably partly to the suppression of mast cell degranulation and partly to protection of the vasculature from mediator challenge.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536160     DOI: 10.1016/0014-2999(94)00627-j

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Cyclooxygenase-2 inhibitory effects and composition of the volatile oil from the dried roots of Lithospermum erythrorhizon.

Authors:  Jyunichi Kawata; Munekazu Kameda; Mitsuo Miyazawa
Journal:  J Nat Med       Date:  2008-01-11       Impact factor: 2.343

2.  Shikonin reduces oedema induced by phorbol ester by interfering with IkappaBalpha degradation thus inhibiting translocation of NF-kappaB to the nucleus.

Authors:  I Andújar; M C Recio; T Bacelli; R M Giner; J L Ríos
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma.

Authors:  Chen-Chen Lee; Chien-Neng Wang; Yu-Ting Lai; Jaw-Jou Kang; Jiunn-Wang Liao; Bor-Luen Chiang; Hui-Chen Chen; Yu-Wen Cheng
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Decreased adiposity and enhanced glucose tolerance in shikonin treated mice.

Authors:  Ahmed Bettaieb; Ellen Hosein; Samah Chahed; Ahlam Abdulaziz; Heidi R Kucera; Nilesh W Gaikwad; Fawaz G Haj
Journal:  Obesity (Silver Spring)       Date:  2015-09-16       Impact factor: 5.002

5.  Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition.

Authors:  Li Lu; Aiping Qin; Hongbiao Huang; Ping Zhou; Chuanyin Zhang; Ningning Liu; Shujue Li; Guanmei Wen; Change Zhang; Weihua Dong; Xuejun Wang; Q Ping Dou; Jinbao Liu
Journal:  Eur J Pharmacol       Date:  2011-03-24       Impact factor: 4.432

6.  Is nitric oxide decrease observed with naphthoquinones in LPS stimulated RAW 264.7 macrophages a beneficial property?

Authors:  Brígida R Pinho; Carla Sousa; Patrícia Valentão; Paula B Andrade
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

7.  Shikonin Suppresses Human T Lymphocyte Activation through Inhibition of IKK β Activity and JNK Phosphorylation.

Authors:  Ting Li; Fenggen Yan; Rui Wang; Hua Zhou; Liang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-16       Impact factor: 2.629

Review 8.  Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.

Authors:  Zhiqin Zhang; Jie Bai; Yawen Zeng; Mengru Cai; Yu Yao; Huimin Wu; Longtai You; Xiaoxv Dong; Jian Ni
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.